Filed: 8/14/2023ACC: 0001892688-23-000068
📋 What this filing means
DARWIN GLOBAL MANAGEMENT, LTD. filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $611.70M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$611.70M
Total AUM (reported)
26.24M
Total Shares
Allocation by class
SPONSORED ADS$274.69M44.9%
COM$230.48M37.7%
SPONSORED ADR$106.53M17.4%
Portfolio Concentration
Top 3$611.70M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 26.24M
Sole
Full voting authority
26.24M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
AMBRX BIOPHARMA INC
SOLEShares16.69M
TypeSH
Market value$274.69M
44.91%
Sole
16.69M
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares9.28M
TypeSH
Market value$230.48M
37.68%
Sole
9.28M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares273.34K
TypeSH
Market value$106.53M
17.42%
Sole
273.34K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AMBRX BIOPHARMA INCSOLE | SPONSORED ADS | 16.69M | SH | $274.69M 44.91% | 16.69M | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 9.28M | SH | $230.48M 37.68% | 9.28M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 273.34K | SH | $106.53M 17.42% | 273.34K | 0.00 | 0.00 |